https://ambrx.com/pipeline/
Some hope for us that are currently fighting hormone sensitive mpc with the knowledge that some day that fight will end and the bugger will learn to get around it. This new research currently in stage 1 trials (very early days) looks impressive and will certainly be one to watch. Their stock price jumped up 45% on just the stage 1 info so certainly the market seems to think it could have legs.
Rob
Looks encouraging and that they are developing treatments which are not only hormone based as with breast ca.
https://www.businesswire.com/news/home/20230216005191/en/ARX517-Ambrx%E2%80%99s-Proprietary-Anti-PSMA-ADC-Shows-Encouraging-Single-Agent-Safety-and-Efficacy-Data-in-Patients-with-Advanced-Prostate-Cancer
Looks very encouraging
Edited by member 20 Feb 2023 at 07:52 | Reason: Not specified
This has made my morning reading this, albeit very early news. Thanks for sharing.
Click through to become a member and gain access to support, information and real time replies.